A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01

Clinical trial NCT06247345 · TERMINATED

Trial details

NCT number: NCT06247345
Sponsor: Alzheimer's Disease Expert Lab (ADEL), Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2024-02-06
Primary completion: 2026-01-07
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.